References
- KAMINSKI JJ, CARU'THERS NI: Highlights from the antial-lergy and gastrointestinal patent literature: January through June 1993. Curr. Opin. Ther. Patents (1993) 3: 1629–1640.
- COHEN N, YAGALOFF KA: Recent progress in the devel-opment of leukotriene B4 antagonists. Curr. Opin. Invest. Drugs (1994) 3: 13–22.
- MANNING P, WATSON R, MARGOLSKEE D, WILLMAS V, SCIIWARZ J, O'BYRNE P: Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4 receptor antagonist. N. Engl. J. Med. (1990) 323: 1736.
- CRAWLEY GC, DOWELL RI, EDWARDS PN, FOSTER SJ, McMILLAN RM, WALKER ERFI, WATERSON D: Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors. J. Med. Chem. (1992) 35: 2600–2609.
- SMITH WL, DEwrrr DL: Differential interactions of pro-staglandin endoperoxide synthetases with nonsteroi-dal anti-inflammatory drugs. Curr. Optn. Invest. Drugs (1994) 3: 1–11,
- VANE J: Towards a better aspirin. Nature (1994) 367: 215–216.
- McELROY AB: Neurokinin receptor antagonists. Curr. Optn. Thera. Patents (1993) 3: 1157–1172.
- LOWE JA, SNIDER RM: The role of tachykinins in puinio-nary disease. Ann. Rep. Med. Chem. (1993) 28: 99–107.
- ICHINOSE M, NAKAJIMA N, TAICAHASHI T, YAMAUCHI H, INOUE H, TAKISHIMA T: Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonists. lancet (1992) 340: 1248–1251.
- KRANTZ A: Proteinases in inflammation. Ann. Rep. Med.Chem. (1993) 28: 187–196.